From the Department of Anesthesiology and Perioperative Medicine.
Department of Medicine, Division of Hospital Medicine.
Anesth Analg. 2022 Nov 1;135(5):1048-1056. doi: 10.1213/ANE.0000000000006185. Epub 2022 Aug 19.
The American Geriatrics Society (AGS) Beers Criteria is an explicit list of potentially inappropriate medications (PIMs) best avoided in adults ≥65 years of age. Cognitively impaired and frail surgical patients often experience poor outcomes after surgery, but the impacts of PIMs on these patients are unclear. Our objective was to assess whether perioperative PIM administration was associated with poor outcomes in geriatric surgical patients. We then evaluated the association between PIM administration and postoperative outcomes in subgroups of patients who were frail or cognitively impaired.
We performed a retrospective cohort study of patients ≥65 years of age who underwent elective inpatient surgery at a large academic medical center from February 2018 to January 2020. Edmonton Frail Scale and Mini-Cog screening tools were administered to all patients at their preoperative clinic visit. A Mini-Cog score of 0 to 2 was considered cognitive impairment, and frailty was defined by an Edmonton Frail Scale score of ≥8. Patients were divided into 2 groups depending on whether they received at least 1 PIM (PIM+), based on the 2019 AGS Beers Criteria, in the perioperative period or none (PIM-). We assessed the association of preoperative frailty, cognitive impairment, and perioperative PIM administration with the length of hospital stay and discharge disposition using multiple regression analyses adjusted for age, sex, ASA physical status, and intensive care unit (ICU) admission.
Of the 1627 included patients (mean age, 73.7 years), 69.3% (n = 1128) received at least 1 PIM. A total of 12.7% of patients were frail, and 11.1% of patients were cognitively impaired; 64% of the frail patients and 58% of the cognitively impaired patients received at least 1 PIM. Perioperative PIM administration was associated with longer hospital stay after surgery (PIM-, 3.56 ± 5.2 vs PIM+, 4.93 ± 5.66 days; P < .001; 95% confidence interval [CI], 0.360-0.546). Frail patients who received PIMs had an average length of stay (LOS) that was nearly 2 days longer than frail patients who did not receive PIMs (PIM-, 4.48 ± 5.04 vs PIM+, 6.33 ± 5.89 days; P = .02). Multiple regression analysis revealed no significant association between PIM administration and proportion of patients discharged to a care facility (PIM+, 26.3% vs PIM-, 28.7%; P = .87; 95% CI, -0.046 to 0.054).
Perioperative PIM administration was common in older surgical patients, including cognitively impaired and frail patients. PIM administration was associated with an increased hospital LOS, particularly in frail patients. There was no association found between PIM administration and discharge disposition.
美国老年医学学会(AGS)的 Beers 标准是一份明确的潜在不适当药物(PIM)清单,最适合避免 65 岁以上的成年人使用。认知障碍和虚弱的手术患者在手术后往往会出现不良结果,但 PIM 对这些患者的影响尚不清楚。我们的目的是评估围手术期 PIM 给药是否与老年手术患者的不良结果相关。然后,我们评估了在认知障碍或虚弱的患者亚组中,PIM 给药与术后结果之间的关联。
我们对 2018 年 2 月至 2020 年 1 月在一家大型学术医疗中心接受择期住院手术的 65 岁以上患者进行了回顾性队列研究。所有患者在术前就诊时均接受埃德蒙顿虚弱量表和迷你认知测验工具的筛查。迷你认知测验评分 0 至 2 分被认为存在认知障碍,而虚弱则定义为埃德蒙顿虚弱量表评分≥8 分。根据 2019 年 AGS Beers 标准,患者根据是否在围手术期接受至少 1 种 PIM(PIM+)分为 2 组,无 PIM(PIM-)。我们使用多回归分析评估了术前虚弱、认知障碍和围手术期 PIM 给药与住院时间和出院去向的关系,调整了年龄、性别、ASA 身体状况和重症监护病房(ICU)入院等因素。
在纳入的 1627 名患者(平均年龄 73.7 岁)中,69.3%(n=1128)接受了至少 1 种 PIM。共有 12.7%的患者虚弱,11.1%的患者认知障碍;64%的虚弱患者和 58%的认知障碍患者接受了至少 1 种 PIM。围手术期 PIM 给药与术后住院时间延长相关(PIM-,3.56±5.2 vs PIM+,4.93±5.66 天;P<0.001;95%置信区间 [CI],0.360-0.546)。接受 PIM 的虚弱患者的平均住院时间比未接受 PIM 的虚弱患者长近 2 天(PIM-,4.48±5.04 vs PIM+,6.33±5.89 天;P=0.02)。多回归分析显示,PIM 给药与患者出院至护理机构的比例之间无显著关联(PIM+,26.3% vs PIM-,28.7%;P=0.87;95% CI,-0.046 至 0.054)。
围手术期 PIM 给药在老年手术患者中很常见,包括认知障碍和虚弱患者。PIM 给药与住院时间延长有关,尤其是在虚弱患者中。PIM 给药与出院去向之间未发现关联。